Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-199114
Filing Date
2009-09-28
Accepted
2009-09-28 17:11:05
Documents
9
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1213343
2 FORM OF EMPLOYMENT AGREEMENT dex1010.htm EX-10.10 21552
3 OFFER LETTER - ROBERT J. LOLLINI dex1011.htm EX-10.11 7090
4 MANAGEMENT PERFORMANCE-INCENTIVE BONUS PROGRAM dex1012.htm EX-10.12 7475
5 CONSENT OF ERNST & YOUNG LLP dex231.htm EX-23.1 1792
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 7652
7 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 7698
8 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER dex321.htm EX-32.1 4624
9 GRAPHIC g39932g29t53.jpg GRAPHIC 15540
  Complete submission text file 0001193125-09-199114.txt   1294175
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
Myriad Pharmaceuticals, Inc. (Filer) CIK: 0001459450 (see all company filings)

EIN.: 263996918 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-34275 | Film No.: 091090827
SIC: 2834 Pharmaceutical Preparations